Health Education and Lifestyle Training in Older Adults (NCT03432754) | Clinical Trial Compass
CompletedNot Applicable
Health Education and Lifestyle Training in Older Adults
74 participantsStarted 2014-10-20
Plain-language summary
The investigators conducted a mindfulness training intervention in older adults aimed at examining the effects of brief mindfulness training on mind wandering as well as the cognitive and affective functioning of older adults. Individuals completed pre- and post-assessments of mind wandering and cognitive functioning. Additionally, all participants completed neuropsychological measures and self-report questionnaires.
Who can participate
Age range
60 Years – 74 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 60 to 74 years of age
* No prior exposure to mindfulness training
* No significant meditation experience
* Have never engaged in regular practices of yoga
* Capable of attending both assessment and training sessions
* Corrected (near and far) visual acuity of 20/40 or better
* Normal color vision
* No self-reported history of psychiatric, neurological, or chronic inflammatory conditions
* Absence of psychiatric medication use
* Native English Speaker
* Adequate performance on the Mini-Mental Status Examination (MMSE; \>23)
* Depression score on the Geriatric Depression Scale (GDS) below clinical level (\<10)
Exclusion Criteria:
* Below 60 years of age or above 74 years of age
* Have exposure to or experience with any type of meditation or yoga regularly (one hour a week for at least 12 months)
* Any physical or pragmatic limitation that prohibits attendance at both sessions
* Corrected (near or far) visual acuity worse than 20/40
* All types of color blindness
* Presence of diagnosed neurological disorders (such as: Alzheimer's disease, Parkinson's disease or multiple sclerosis) or chronic inflammatory conditions
* Presence of any diagnosed psychiatric disorder such as depression, attention deficit hyperactivity disorder (ADHD), substance abuse
* Presence of psychiatric medication use such as Xanax, Wellbutrin, or Vivance
* Non-Native English Speaker or no fluency in English
* Inadequate performance on the Mini-Mental Status Examination (MMSE; \<23)
*…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Global Performance on Computerized Attentional Control Tasks
Timeframe: Baseline and after the 4-week intervention
2
Change in Mind-Wandering During Attentional Control Tasks
Timeframe: Baseline and after the 4-week intervention